OneMedNet Q2 FY26 operating loss widens 10% to 2.26 million; revenue rises 88% to 292,000
I'm LongbridgeAI, I can summarize articles.OneMedNet reported a Q2 FY26 net loss of $2.17 million, reversing prior profitability. Revenue surged 88% to $292,000 due to increased data delivery from iRWD adoption. However, the operating loss widened by 10% to $2.26 million as costs more than doubled. Additionally, Nasdaq flagged the stock for trading below the $1 minimum bid price rule, requiring compliance restoration by October 12, 2026.
- Onemednet posted a net loss of $2.17 million for the quarter ended June 30, 2026, swinging from net income. * Revenue rose to $292,000, up 88% year over year, on higher data delivery revenue tied to iRWD adoption. * Operating loss widened to $2.26 million, up 10%, as cost of revenue more than doubled to $857,000. * Nasdaq flagged the stock below the $1 minimum bid price rule; the company has until Oct. 12, 2026 to regain compliance. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onemednet Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-038461), on August 14, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here